Neuroleptics in progressive structural brain abnormalities in psychiatric illness

Lancet

Volumn 352, Issue 9130, 1998, Pages 784-785

  Madsen, A L ^a   Keiding, N ^a   Kade, A ^a   Esbjerg, S ^a   Hemmingsen, R ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FRONTAL LOBE; HUMAN; NEUROPATHOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032486972     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60678-2     Document Type: Article

References (5)

1. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. PsychiatrRes 1997; 7: 129-40.
2. Andreasen NC, Black DW, Introductory textbook of psychiatry. Washington DC: American Psychiatric Press, 1991.
3. Friedman L, Knutson L, Shurell M, et al, Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. B loi Psychiatry 1991; 29: 865-77.
4. Sandyk R, Kay SR, Sulcal size and neuroleptic-induced akathisia. B loi Psychiatry 1990: 27: 466-67.
5. Frazier JA, Giedd JN, Kaysen D, et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1 996; 153: 4.